Abnormal erythropoiesis and the pathophysiology of chronic anemia

Blood Reviews

Volumn 28, Issue 2, 2014, Pages 49-66

  Koury, Mark J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic anemia; Erythroid differentiation; Erythropoiesis; Macrocytic anemia; Microcytic anemia; Pathophysiology of anemia

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; APLASTIC ANEMIA; BLOOD CELL COUNT; BONE MARROW DEPRESSION; CELL DIFFERENTIATION; CELL SIZE; CHRONIC INFLAMMATION; ERYTHROBLAST; ERYTHROCYTE LIFESPAN; ERYTHROCYTE MEMBRANE; ERYTHROPOIESIS; HEMATOCRIT; HEMATOPOIETIC STEM CELL; HEME SYNTHESIS; HEMOGLOBIN SYNTHESIS; HUMAN; IRON DEFICIENCY; IRON METABOLISM; LEUKOCYTE COUNT; MACROCYTIC ANEMIA; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEGALOBLASTIC ANEMIA; MEGALOCYTOSIS; MICROCYTIC ANEMIA; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOID METAPLASIA; PANCYTOPENIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETICULOCYTE; REVIEW; SPLENOMEGALY; THALASSEMIA; THROMBOCYTE COUNT;

CHRONIC ANEMIA; ERYTHROID DIFFERENTIATION; ERYTHROPOIESIS; MACROCYTIC ANEMIA; MICROCYTIC ANEMIA; PATHOPHYSIOLOGY OF ANEMIA;

ANEMIA; ANIMALS; BLOOD CELL COUNT; BLOOD PLATELETS; CELL DIFFERENTIATION; CHRONIC DISEASE; ERYTHROCYTES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HUMANS; LEUKOCYTES;

EID: 84896081488     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2014.01.002     Document Type: Article

References (232)

1. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000, 37:93-130.
2. d'Onofrio G., Chirillo R., Zini G., Caenaro G., Tommasi M., Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995, 85:818-823.
3. Ney P.A. Normal and disordered reticulocyte maturation. Curr Opin Hematol 2011, 18:152-157.
4. Willekens F.L., Werre J.M., Groenen-Dopp Y.A., Roerdinkholder-Stoelwinder B., de Pauw B., Bosman G.J. Erythrocyte vesiculation: a self-protective mechanism?. Br J Haematol 2008, 141:549-556.
5. van Krieken J.H., te Velde J. Normal histology of the human spleen. Am J Surg Pathol 1988, 12:777-785.
6. Kiefer C.R., Snyder L.M. Oxidation and erythrocyte senescence. Curr Opin Hematol 2000, 7:113-116.
7. Arese P., Turrini F., Schwarzer E. Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005, 16:133-146.
8. Kay M.M. Localization of senescent cell antigen on band 3. Proc Natl Acad Sci U S A 1984, 81:5753-5757.
9. Low P.S., Waugh S.M., Zinke K., Drenckhahn D. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science 1985, 227:531-533.
10. Connor J., Pak C.C., Schroit A.J. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994, 269:2399-2404.
11. Lutz H.U., Nater M., Stammler P. Naturally occurring anti-band 3 antibodies have a unique affinity for C3. Immunology 1993, 80:191-196.
12. Oldenborg P.A. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma 2004, 45:1319-1327.
13. Burger P., Hilarius-Stokman P., de Korte D., van den Berg T.K., van Bruggen R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 2012, 119:5512-5521.
14. Franco R.S., Puchulu-Campanella M.E., Barber L.A., Palascak M.B., Joiner C.H., Low P.S., et al. Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol 2013, 88:44-51.
15. Buttarello M., Bulian P., Farina G., Temporin V., Toffolo L., Trabuio E., et al. Flow cytometric reticulocyte counting. Parallel evaluation of five fully automated analyzers: an NCCLS-ICSH approach. Am J Clin Pathol 2001, 115:100-111.
16. Aoki M., Tavassoli M. Dynamics of red cell egress from bone marrow after blood letting. Br J Haematol 1981, 49:337-347.
17. Koury M.J. Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp Hematol 2005, 33:1263-1270.
18. Koury S.T., Koury M.J., Bondurant M.C., Caro J., Graber S.E. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989, 74:645-651.
19. Obara N., Suzuki N., Kim K., Nagasawa T., Imagawa S., Yamamoto M. Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 2008, 111:5223-5232.
20. Lippi G., Franchini M., Favaloro E.J. Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost 2010, 36:537-549.
21. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
22. Smith J.N., Calvi L.M. Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 2013, 31:1044-1050.
23. Gregory C.J., Eaves A.C. Human marrow cells capable of erythropoietic differentiation in vitro: definition of three erythroid colony responses. Blood 1977, 49:855-864.
24. Pina C., Fugazza C., Tipping A.J., Brown J., Soneji S., Teles J., et al. Inferring rules of lineage commitment in haematopoiesis. Nat Cell Biol 2012, 14:287-294.
25. Hattangadi S.M., Wong P., Zhang L., Flygare J., Lodish H.F. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 2011, 118:6258-6268.
26. Arinobu Y., Mizuno S., Chong Y., Shigematsu H., Iino T., Iwasaki H., et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007, 1:416-427.
27. Mancini E., Sanjuan-Pla A., Luciani L., Moore S., Grover A., Zay A., et al. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J 2012, 31:351-365.
28. Siatecka M., Bieker J.J. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood 2011, 118:2044-2054.
29. An X., Mohandas N. Erythroblastic islands, terminal erythroid differentiation and reticulocyte maturation. Int J Hematol 2011, 93:139-143.
30. Manwani D., Bieker J.J. The erythroblastic island. Curr Top Dev Biol 2008, 82:23-53.
31. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112:470-478.
32. Rhodes M.M., Kopsombut P., Bondurant M.C., Price J.O., Koury M.J. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 2008, 111:1700-1708.
33. Nagata S. Autoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors. Immunol Rev 2007, 220:237-250.
34. Lee W.B., Erm S.K., Kim K.Y., Becker R.P. Emperipolesis of erythroblasts within Kupffer cells during hepatic hemopoiesis in human fetus. Anat Rec 1999, 256:158-164.
35. Stephenson J.R., Axelrad A.A., McLeod D.L., Shreeve M.M. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci U S A 1971, 68:1542-1546.
36. Nijhof W., Wierenga P.K. Isolation and characterization of the erythroid progenitor cell: CFU-E. J Cell Biol 1983, 96:386-392.
37. Sawada K., Krantz S.B., Kans J.S., Dessypris E.N., Sawyer S., Glick A.D., et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest 1987, 80:357-366.
38. -/- mice due to decreased survival of early erythroblasts. Blood 2001, 98:3261-3273.
39. Chen K., Liu J., Heck S., Chasis J.A., An X., Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci U S A 2009, 106:17413-17418.
40. Hu J., Liu J., Xue F., Halverson G., Reid M., Guo A., et al. Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo. Blood 2013, 121:3246-3253.
41. Dai C.H., Krantz S.B., Zsebo K.M. Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood 1991, 78:2493-2497.
42. Koury M.J., Bondurant M.C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990, 248:378-381.
43. Wu H., Liu X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995, 83:59-67.
44. Bondurant M.C., Koury M.J. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol Cell Biol 1986, 6:2731-2733.
45. Eckardt K.U., Kurtz A. Regulation of erythropoietin production. Eur J Clin Invest 2005, 35(Suppl. 3):13-19.
46. Haase V.H. Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev 2013, 27:41-53.
47. Richmond T.D., Chohan M., Barber D.L. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 2005, 15:146-155.
48. Rubiolo C., Piazzolla D., Meissl K., Beug H., Huber J.C., Kolbus A., et al. A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood 2006, 108:152-159.
49. Liu J., Mohandas N., An X. Membrane assembly during erythropoiesis. Curr Opin Hematol 2011, 18:133-138.
50. De Maria R., Testa U., Luchetti L., Zeuner A., Stassi G., Pelosi E., et al. Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis. Blood 1999, 93:796-803.
51. Koulnis M., Porpiglia E., Porpiglia P.A., Liu Y., Hallstrom K., Hidalgo D., et al. Contrasting dynamic responses in vivo of the Bcl-xL and Bim erythropoietic survival pathways. Blood 2012, 119:1228-1239.
52. Panzenbock B., Bartunek P., Mapara M.Y., Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood 1998, 92:3658-3668.
53. von Lindern M., Zauner W., Mellitzer G., Steinlein P., Fritsch G., Huber K., et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999, 94:550-559.
54. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 1999, 13:2996-3002.
55. Paulson R.F., Shi L., Wu D.C. Stress erythropoiesis: new signals and new stress progenitor cells. Curr Opin Hematol 2011, 18:139-145.
56. Zhang L., Prak L., Rayon-Estrada V., Thiru P., Flygare J., Lim B., et al. ZFP36L2 is required for self-renewal of early burst-forming unit erythroid progenitors. Nature 2013, 499:92-96.
57. Millot S., Andrieu V., Letteron P., Lyoumi S., Hurtado-Nedelec M., Karim Z., et al. Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. Blood 2010, 116:6072-6081.
58. Ramos P., Casu C., Gardenghi S., Breda L., Crielaard B.J., Guy E., et al. Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia. Nat Med 2013, 19:437-445.
59. Sadahira Y., Yasuda T., Yoshino T., Manabe T., Takeishi T., Kobayashi Y., et al. Impaired splenic erythropoiesis in phlebotomized mice injected with CL2MDP-liposome: an experimental model for studying the role of stromal macrophages in erythropoiesis. J Leukoc Biol 2000, 68:464-470.
60. + macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 2013, 19:429-436.
61. L prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin. Blood 2005, 106:1857-1863.
62. Merika M., Orkin S.H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 1995, 15:2437-2447.
63. Gregory R.C., Taxman D.J., Seshasayee D., Kensinger M.H., Bieker J.J., Wojchowski D.M. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood 1996, 87:1793-1801.
64. Zhao G., Yu D., Weiss M.J. MicroRNAs in erythropoiesis. Curr Opin Hematol 2010, 17:155-162.
65. Byon J.C., Papayannopoulou T. MicroRNAs: allies or foes in erythropoiesis?. J Cell Physiol 2012, 227:7-13.
66. Hu W., Yuan B., Flygare J., Lodish H.F. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev 2011, 25:2573-2578.
67. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997, 89:1-25.
68. Koury M.J., Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr 2004, 24:105-131.
69. Zhang A.S., Sheftel A.D., Ponka P. Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria. Blood 2005, 105:368-375.
70. Chen W., Dailey H.A., Paw B.H. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis. Blood 2010, 116:628-630.
71. Shah D.I., Takahashi-Makise N., Cooney J.D., Li L., Schultz I.J., Pierce E.L., et al. Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature 2012, 491:608-612.
72. Chiabrando D., Marro S., Mercurio S., Giorgi C., Petrillo S., Vinchi F., et al. The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation. J Clin Invest 2012, 122:4569-4579.
73. Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci 2004, 1012:1-13.
74. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2006, 2:406-414.
75. Schranzhofer M., Schifrer M., Cabrera J.A., Soe-Lin S., Sheftel A.D., Mullner E.W., et al. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood 2006, 107:4159-4167.
76. Sawyer S.T., Krantz S.B. Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. J Biol Chem 1986, 261:9187-9195.
77. Koury M.J., Sawyer S.T., Bondurant M.C. Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation. J Cell Physiol 1984, 121:526-532.
78. Bondurant M.C., Lind R.N., Koury M.J., Ferguson M.E. Control of globin gene transcription by erythropoietin in erythroblasts from friend virus-infected mice. Mol Cell Biol 1985, 5:675-683.
79. Sun J., Brand M., Zenke Y., Tashiro S., Groudine M., Igarashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci U S A 2004, 101:1461-1466.
80. Zenke-Kawasaki Y., Dohi Y., Katoh Y., Ikura T., Ikura M., Asahara T., et al. Heme induces ubiquitination and degradation of the transcription factor Bach1. Mol Cell Biol 2007, 27:6962-6971.
81. Kim S.I., Bresnick E.H. Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene 2007, 26:6777-6794.
82. Chen J.J. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 2007, 109:2693-2699.
83. Mollan T.L., Yu X., Weiss M.J., Olson J.S. The role of alpha-hemoglobin stabilizing protein in redox chemistry, denaturation, and hemoglobin assembly. Antioxid Redox Signal 2010, 12:219-231.
84. Dickson C.F., Rich A.M., D'Avigdor W.M., Collins D.A., Lowry J.A., Mollan T.L., et al. Alpha-hemoglobin-stabilizing protein (AHSP) perturbs the proximal heme pocket of oxy-alpha-hemoglobin and weakens the iron-oxygen bond. J Biol Chem 2013, 288:19986-20001.
85. Han A.P., Fleming M.D., Chen J.J. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest 2005, 115:1562-1570.
86. Dolznig H., Bartunek P., Nasmyth K., Mullner E.W., Beug H. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of d-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ 1995, 6:1341-1352.
87. Dolznig H., Boulme F., Stangl K., Deiner E.M., Mikulits W., Beug H., et al. Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J 2001, 15:1442-1444.
88. Sankaran V.G., Ludwig L.S., Sicinska E., Xu J., Bauer D.E., Eng J.C., et al. Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. Genes Dev 2012, 26:2075-2087.
89. Gregory T.R. The bigger the C-value, the larger the cell: genome size and red blood cell size in vertebrates. Blood Cells Mol Dis 2001, 27:830-843.
90. Kelley L.L., Koury M.J., Bondurant M.C., Koury S.T., Sawyer S.T., Wickrema A. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993, 82:2340-2352.
91. Ji P., Murata-Hori M., Lodish H.F. Formation of mammalian erythrocytes: chromatin condensation and enucleation. Trends Cell Biol 2011, 21:409-415.
92. Koury S.T., Koury M.J., Bondurant M.C. Cytoskeletal distribution and function during the maturation and enucleation of mammalian erythroblasts. J Cell Biol 1989, 109:3005-3013.
93. Shearstone J.R., Pop R., Bock C., Boyle P., Meissner A., Socolovsky M. Global DNA demethylation during mouse erythropoiesis in vivo. Science 2011, 334:799-802.
94. Barde I., Rauwel B., Marin-Florez R.M., Corsinotti A., Laurenti E., Verp S., et al. A KRAB/KAP1-miRNA cascade regulates erythropoiesis through stage-specific control of mitophagy. Science 2013, 340:350-353.
95. Ubukawa K., Guo Y.M., Takahashi M., Hirokawa M., Michishita Y., Nara M., et al. Enucleation of human erythroblasts involves non-muscle myosin IIB. Blood 2012, 119:1036-1044.
96. Porcu S., Manchinu M.F., Marongiu M.F., Sogos V., Poddie D., Asunis I., et al. Klf1 affects DNase II-alpha expression in the central macrophage of a fetal liver erythroblastic island: a non-cell-autonomous role in definitive erythropoiesis. Mol Cell Biol 2011, 31:4144-4154.
97. Koury M.J., Rhodes M. How to approach chronic anemia. Hematology Am Soc Hematol Educ Program 2012, 2012:183-190.
98. Thiele J., Kvasnicka H.M. Myelofibrosis in chronic myeloproliferative disorders-dynamics and clinical impact. Histol Histopathol 2006, 21:1367-1378.
99. Thiele J., Kvasnicka H.M. Hematopathologic findings in chronic idiopathic myelofibrosis. Semin Oncol 2005, 32:380-394.
100. Sadahira Y., Wada H., Manabe T., Yawata Y. Immunohistochemical assessment of human bone marrow macrophages in hematologic disorders. Pathol Int 1999, 49:626-632.
101. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 2005, 23:8520-8530.
102. Le Bousse-Kerdiles M.C., Martyre M.C., Samson M. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review. Eur Cytokine Netw 2008, 19:69-80.
103. Broseus J., Florensa L., Zipperer E., Schnittger S., Malcovati L, Richebourg S., et al. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis. Haematologica 2012, 97:1036-1041.
104. Griesshammer M., Bangerter M., Sauer T., Wennauer R., Bergmann L., Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 1999, 245:295-300.
105. Rose S.R., Petersen N.J., Gardner T.J., Hamill R.J., Trautner B.W. Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res 2012, 4:415-423.
106. Barton J.C., Bertoli L.F. Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients. BMC Blood Disord 2010, 10:9.
107. Kuku I., Kaya E., Yologlu S., Gokdeniz R., Baydin A. Platelet counts in adults with iron deficiency anemia. Platelets 2009, 20:401-405.
108. Kadikoylu G., Yavasoglu I., Bolaman Z., Senturk T. Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc 2006, 98:398-402.
109. Akan H., Guven N., Aydogdu I., Arat M., Beksac M., Dalva K. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis. Acta Haematol 2000, 103:152-156.
110. Weinzierl E.P., Arber D.A. Bone marrow evaluation in new-onset pancytopenia. Hum Pathol 2013, 44:1154-1164.
111. Devitt K.A., Lunde J.H., Lewis M.R. New onset pancytopenia in adults: a review of underlying pathologies and their associated clinical and laboratory findings. Leuk Lymphoma 2013, 10.3109/10428194.2013.821703.
112. Brodsky R.A., Jones R.J. Aplastic anaemia. Lancet 2005, 365:1647-1656.
113. Young N.S., Bacigalupo A., Marsh J.C. Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transplant 2010, 16:S119-S125.
114. + T regulatory cells in acquired aplastic anemia. Blood 2007, 110:1603-1606.
115. Morinet F., Leruez-Ville M., Pillet S., Fichelson S. Concise review: anemia caused by viruses. Stem Cells 2011, 29:1656-1660.
116. Nixon C.C., Vatakis D.N., Reichelderfer S.N., Dixit D., Kim S.G., Uittenbogaart C.H., et al. HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice. Blood 2013, 122:2195-2204.
117. Wan Z., Zhi N., Wong S., Liu D., Raghavachari N., Munson P.J., et al. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 2010, 120:3530-3544.
118. Sol N., Le Junter J., Vassias I., Freyssinier J.M., Thomas A., Prigent A.F., et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999, 73:8762-8770.
119. Raza A., Gezer S., Mundle S., Gao X.Z., Alvi S., Borok R., et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995, 86:268-276.
120. DeZern A.E., Pu J., McDevitt M.A., Jones R.J., Brodsky R.A. Burst-forming unit-erythroid assays to distinguish cellular bone marrow failure disorders. Exp Hematol 2013, 41:808-816.
121. Kerbauy D.B., Deeg H.J. Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome. Exp Hematol 2007, 35:1739-1746.
122. Ebert B.L., Pretz J., Bosco J., Chang C.Y., Tamayo P., Galili N., et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
123. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
124. Boultwood J., Pellagatti A., Nikpour M., Pushkaran B., Fidler C., Cattan H., et al. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 2008, 3:e1970.
125. Tehranchi R., Invernizzi R., Grandien A., Zhivotovsky B., Fadeel B., Forsblom A.M., et al. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood 2005, 106:247-253.
126. Yoshida K., Sanada M., Shiraishi Y., Nowak D., Nagata Y., Yamamoto R., et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011, 478:64-69.
127. Papaemmanuil E., Cazzola M., Boultwood J., Malcovati L., Vyas P., Bowen D., et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011, 365:1384-1395.
128. Houwerzijl E.J., Pol H.W., Blom N.R., van der Want J.J., de Wolf J.T., Vellenga E. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria. Leukemia 2009, 23:886-891.
129. Lin C.K., Hsu H.C., Chau W.K., Jiang M.L., Chiu C.F. Reticulocyte count with maturation fractions in pancytopenic evaluation by a fully automated counter. J Clin Lab Anal 1993, 7:371-375.
130. Burke J.S. Surgical pathology of the spleen: an approach to the differential diagnosis of splenic lymphomas and leukemias. Part I. Diseases of the white pulp. Am J Surg Pathol 1981, 5:551-563.
131. Burke J.S. Surgical pathology of the spleen: an approach to the differential diagnosis of splenic lymphomas and leukemias. Part II. Diseases of the red pulp. Am J Surg Pathol 1981, 5:681-694.
132. Toghill P.J., Green S. Splenic influences on the blood in chronic liver disease. Q J Med 1979, 48:613-625.
133. Shah S.H., Hayes P.C., Allan P.L., Nicoll J., Finlayson N.D. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 1996, 91:2580-2583.
134. Toghill P.J., Green S. The influence of spleen size on the distribution of red cells and plasma. J Clin Pathol 1972, 25:570-573.
135. Christensen B.E. Erythrocyte pooling and sequestration in enlarged spleens. Estimations of splenic erythrocyte and plasma volume in splenomegalic patients. Scand J Haematol 1973, 10:106-119.
136. Christensen B.E. Quantitative determination of splenic red blood cell destruction in patients with splenomegaly. Scand J Haematol 1975, 14:295-302.
137. Buffet P.A., Safeukui I., Milon G., Mercereau-Puijalon O., David P.H. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr Opin Hematol 2009, 16:157-164.
138. Safeukui I., Buffet P.A., Perrot S., Sauvanet A., Aussilhou B., Dokmak S., et al. Surface area loss and increased sphericity account for the splenic entrapment of subpopulations of Plasmodium falciparum ring-infected erythrocytes. PLoS One 2013, 8:e60150.
139. Heegaard E.D., Brown K.E. Human parvovirus B19. Clin Microbiol Rev 2002, 15:485-505.
140. Brown K.E., Anderson S.M., Young N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993, 262:114-117.
141. Erslev A.J., Soltan A. Pure red-cell aplasia: a review. Blood Rev 1996, 10:20-28.
142. Casadevall N., Nataf J., Viron B., Kolta A., Kiladjian J.J., Martin-Dupont P., et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002, 346:469-475.
143. Nangaku M., Eckardt K.U. Pathogenesis of renal anemia. Semin Nephrol 2006, 26:261-268.
144. Erslev A.J. Erythropoietin. N Engl J Med 1991, 324:1339-1344.
145. Baer A.N., Dessypris E.N., Goldwasser E., Krantz S.B. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987, 66:559-564.
146. Miller C.B., Jones R.J., Piantadosi S., Abeloff M.D., Spivak J.L. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990, 322:1689-1692.
147. Frede S., Fandrey J., Pagel H., Hellwig T., Jelkmann W. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol 1997, 273:R1067-R1071.
148. Souma T., Yamazaki S., Moriguchi T., Pan X., Minegishi N., Suzuki N., et al. Plasticity of renal erythropoietin-producing cells governs fibrosis. J Am Soc Nephrol 2013, 24:1599-1616.
149. Dallman P.R., Siimes M.A. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr 1979, 94:26-31.
150. Brugnara C., Mohandas N. Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium. Curr Opin Hematol 2013, 20:222-230.
151. Leberbauer C., Boulme F., Unfried G., Huber J., Beug H., Mullner E.W. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors. Blood 2005, 105:85-94.
152. Horton L., Coburn R.J., England J.M., Himsworth R.L. The haematology of hypothyroidism. Q J Med 1976, 45:101-123.
153. Savage D.G., Ogundipe A., Allen R.H., Stabler S.P., Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000, 319:343-352.
154. Seppa K., Laippala P., Saarni M. Macrocytosis as a consequence of alcohol abuse among patients in general practice. Alcohol Clin Exp Res 1991, 15:871-876.
155. Mahmoud M.Y., Lugon M., Anderson C.C. Unexplained macrocytosis in elderly patients. Age Ageing 1996, 25:310-312.
156. Maruyama S., Hirayama C., Yamamoto S., Koda M., Udagawa A., Kadowaki Y., et al. Red blood cell status in alcoholic and non-alcoholic liver disease. J Lab Clin Med 2001, 138:332-337.
157. Odewole O.A., Williamson R.S., Zakai N.A., Berry R.J., Judd S.E., Qi Y.P, et al. Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: reasons for geographic and racial differences in stroke study 2003-2007. Am J Clin Nutr 2013, 98:1042-1047.
158. Koury M.J., Horne D.W., Brown Z.A., Pietenpol J.A., Blount B.C., Ames B.N., et al. Apoptosis of late-stage erythroblasts in megaloblastic anemia: association with DNA damage and macrocyte production. Blood 1997, 89:4617-4623.
159. Shane B., Stokstad E.L. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985, 5:115-141.
160. Herbert V., Zalusky R. Interrelations of vitamin B12 and folic acid metabolism: folic acid clearance studies. J Clin Invest 1962, 41:1263-1276.
161. Noronha J.M., Silverman M. On folic acid, vitamin B-12, methionine, and formiminoglutamate metabolism. Vitamin B-12 and Intrinsic Factor, 2nd Eur Symp 1962, 728-736. Ferdinand Enke, Stuttgart. H.C. Heinrich (Ed.).
162. Koury M.J., Price J.O., Hicks G.G. Apoptosis in megaloblastic anemia occurs during DNA synthesis by a p53-independent, nucleoside-reversible mechanism. Blood 2000, 96:3249-3255.
163. Herzlich B.C., Ranginwala M., Nawabi I., Herbert V. Synergy of inhibition of DNA synthesis in human bone marrow by azidothymidine plus deficiency of folate and/or vitamin B12?. Am J Hematol 1990, 33:177-183.
164. Wickramasinghe S.N., Dodsworth H., Rault R.M., Hulme B. Observations on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation. Transplantation 1974, 18:443-446.
165. Paz-Ares L., Donehower R.C. Hydroxyurea. Cancer Chemotherapy and Biotherapy: Principles and Practice 2001, 315-328. Lippincott Williams and Wilkins, Philadelphia. 3rd ed. B.A. Chabner, D.L. Longo (Eds.).
166. Parikh S., Bessler M. Recent insights into inherited bone marrow failure syndromes. Curr Opin Pediatr 2012, 24:23-32.
167. Pant V., Quintas-Cardama A., Lozano G. The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans. Blood 2012, 120:5118-5127.
168. Kee Y., D'Andrea A.D. Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest 2012, 122:3799-3806.
169. Calado R.T., Young N.S. Telomere diseases. N Engl J Med 2009, 361:2353-2365.
170. Dokal I. Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program 2011, 2011:480-486.
171. Horos R., von Lindern M. Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia. Br J Haematol 2012, 159:514-527.
172. Heiss N.S., Knight S.W., Vulliamy T.J., Klauck S.M., Wiemann S., Mason P.J., et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998, 19:32-38.
173. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
174. Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 2008, 10:1923-1940.
175. Suragani R.N., Zachariah R.S., Velazquez J.G., Velazquez J.C., Liu S., Sun C.W., et al. Heme-regulated eIF2alpha kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis. Blood 2012, 119:5276-5284.
176. Han A.P., Yu C., Lu L., Fujiwara Y., Browne C., Chin G., et al. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J 2001, 20:6909-6918.
177. Pasricha S.R., Drakesmith H., Black J., Hipgrave D., Biggs B.A. Control of iron deficiency anemia in low- and middle-income countries. Blood 2013, 121:2607-2617.
178. Hershko C., Skikne B. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis. Semin Hematol 2009, 46:339-350.
179. Nemeth E., Tuttle M.S., Powelson J., Vaughn MB., Donovan A., Ward D.M, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
180. Ganz T., Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 1823, 2012:1434-1443.
181. Zhao N., Zhang A.S., Enns C.A. Iron regulation by hepcidin. J Clin Invest 2013, 123:2337-2343.
182. Cianetti L., Segnalini P., Calzolari A., Morsilli O., Felicetti F., Ramoni C., et al. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Haematologica 2005, 90:1595-1606.
183. Zhang D.L., Hughes R.M., Ollivierre-Wilson H., Ghosh M.C., Rouault T.A. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 2009, 9:461-473.
184. Zhang D.L., Senecal T., Ghosh M.C., Ollivierre-Wilson H., Tu T., Rouault T.A. Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. Blood 2011, 118:2868-2877.
185. Ghosh M.C., Zhang D.L., Jeong S.Y., Kovtunovych G., Ollivierre-Wilson H., Noguchi A., et al. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metab 2013, 17:271-281.
186. Anderson S.A., Nizzi C.P., Chang Y.I., Deck K.M., Schmidt P.J., Galy B., et al. The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metab 2013, 17:282-290.
187. Wilkinson N., Pantopoulos K. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2alpha mRNA translation. Blood 2013, 122:1658-1668.
188. Weatherall D.J. Pathophysiology of thalassaemia. Baillieres Clin Haematol 1998, 11:127-146.
189. Pootrakul P., Sirankapracha P., Hemsorach S., Moungsub W., Kumbunlue R., Piangitjagum A., et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood 2000, 96:2606-2612.
190. Khandros E., Thom C.S., D'Souza J., Weiss M.J. Integrated protein quality-control pathways regulate free alpha-globin in murine beta-thalassemia. Blood 2012, 119:5265-5275.
191. Schrier S.L. Pathophysiology of thalassemia. Curr Opin Hematol 2002, 9:123-126.
192. Cappellini M.D., Tavazzi D., Duca L., Graziadei G., Mannu F., Turrini F., et al. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Br J Haematol 1999, 104:504-512.
193. Kuypers F.A., Yuan J., Lewis R.A., Snyder L.M., Kiefer C.R., Bunyaratvej A., et al. Membrane phospholipid asymmetry in human thalassemia. Blood 1998, 91:3044-3051.
194. Centis F., Tabellini L., Lucarelli G., Buffi O., Tonucci P., Persini B., et al. The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood 2000, 96:3624-3629.
195. Ginzburg Y., Rivella S. beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 2011, 118:4321-4330.
196. Mastrogiannaki M., Matak P., Mathieu J.R., Delga S., Mayeux P., Vaulont S., et al. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica 2012, 97:827-834.
197. Liu Q., Davidoff O., Niss K., Haase V.H. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 2012, 122:4635-4644.
198. Papanikolaou N.C., Hatzidaki E.G., Belivanis S., Tzanakakis G.N., Tsatsakis A.M. Lead toxicity update. A brief review. Med Sci Monit 2005, 11:RA329-RA336.
199. Gawarammana I.B., Dargan P.I., Woodcock S., Sculley M., House I.M., Wood D.M., et al. Should all patients with unexplained anaemia be screened for chronic lead poisoning?. Hum Exp Toxicol 2006, 25:645-649.
200. Camaschella C. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Semin Hematol 2009, 46:371-377.
201. Iolascon A., De Falco L., Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica 2009, 94:395-408.
202. Ohba R., Furuyama K., Yoshida K., Fujiwara T., Fukuhara N., Onishi Y., et al. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann Hematol 2013, 92:1-9.
203. Taketani S., Kakimoto K., Ueta H., Masaki R., Furukawa T. Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 2003, 101:3274-3280.
204. Ye H., Jeong S.Y., Ghosh M.C., Kovtunovych G., Silvestri L., Ortillo D., et al. Glutaredoxin 5 deficiency causes sideroblastic anemia by specifically impairing heme biosynthesis and depleting cytosolic iron in human erythroblasts. J Clin Invest 2010, 120:1749-1761.
205. Craig G.M., Elliot C., Hughes K.R. Masked vitamin B12 and folate deficiency in the elderly. Br J Nutr 1985, 54:613-619.
206. Savage D., Lindenbaum J. Anemia in alcoholics. Medicine 1986, 65:322-338.
207. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
208. Davis S.L., Littlewood T.J. The investigation and treatment of secondary anaemia. Blood Rev 2012, 26:65-71.
209. Roy C.N. Anemia of inflammation. Hematology Am Soc Hematol Educ Program 2010, 2010:276-280.
210. Wrighting D.M., Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006, 108:3204-3209.
211. Verga Falzacappa M.V., Vujic Spasic M., Kessler R., Stolte J., Hentze M.W., Muckenthaler M.U. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007, 109:353-358.
212. Pietrangelo A., Dierssen U., Valli L., Garuti C., Rump A., Corradini E., et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 2007, 132:294-300.
213. Besson-Fournier C., Latour C., Kautz L., Bertrand J., Ganz T., Roth M.P., et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 2012, 120:431-439.
214. Theurl I., Schroll A., Nairz M., Seifert M, Theurl M., Sonnweber T., et al. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica 2011, 96:1761-1769.
215. Theurl I., Aigner E., Theurl M., Nairz M, Seifert M., Schroll A., et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113:5277-5286.
216. Cheng P.P., Jiao X.Y., Wang X.H., Lin J.H., Cai Y.M. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med 2011, 11:33-42.
217. van Santen S., van Dongen-Lases E.C., de Vegt F., Laarakkers C.M., van Riel P.L., van Ede A.E., et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 2011, 63:3672-3680.
218. Keel S.B., Abkowitz J.L. The microcytic red cell and the anemia of inflammation. N Engl J Med 2009, 361:1904-1906.
219. Libregts S.F., Gutierrez L., de Bruin A.M., Wensveen F.M., Papadopoulos P., van Ijcken W., et al. Chronic IFN-gamma production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis. Blood 2011, 118:2578-2588.
220. Richardson C.L., Delehanty L.L., Bullock G.C., Rival C.M., Tung K.S., Kimpel D.L., et al. Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response. J Clin Invest 2013, 123:3614-3623.
221. Morceau F., Dicato M., Diederich M. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis. Mediators Inflamm 2009, 2009:405016.
222. Weiss G., Schett G. Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol 2013, 9:205-215.
223. Dai C.H., Price J.O., Brunner T., Krantz S.B. Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. Blood 1998, 91:1235-1242.
224. Felli N., Pedini F., Zeuner A., Petrucci E., Testa U., Conticello C., et al. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol 2005, 175:1464-1472.
225. Suehiro Y., Muta K., Nakashima M., Abe Y., Shiratsuchi M., Shiokawa S., et al. A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1. Eur J Haematol 2005, 74:365-373.
226. Beguin Y., Yerna M., Loo M., Weber M., Fillet G. Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br J Haematol 1992, 82:648-653.
227. Fossa A., Brandhorst D., Myklebust J.H., Seeber S., Nowrousian M.R. Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma. Exp Hematol 1999, 27:1621-1626.
228. + hematopoietic stem and progenitor cells. Blood 2012, 120:2620-2630.
229. + highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood 2002, 99:1305-1313.
230. Maes K., Nemeth E., Roodman G.D., Huston A., Esteve F., Freytes C., et al. In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 2010, 116:3635-3644.
231. Piva E., Brugnara C., Chiandetti L., Plebani M. Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med 2010, 48:1369-1380.
232. Higgins J.M., Mahadevan L. Physiological and pathological population dynamics of circulating human red blood cells. Proc Natl Acad Sci U S A 2010, 107:20587-20592.